DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Visudyne (Verteporfin) - Current Clinical Trials

 
 



Visudyne Related Clinical Trials

Phase II Pilot Study of Visudyne´┐Ż Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. [Completed]

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) [Completed]

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Completed]

A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Completed]

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) [Completed]

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy [Completed]

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Terminated]

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration [Completed]

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment [Completed]

Visudyne« in Occult (VIO) [Completed]

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV [Completed]

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) [Terminated]

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD [Recruiting]

Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Recruiting]

Visual Outcome in Patients With Symptomatic Macular PCV Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy. [Active, not recruiting]

Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy [Completed]

ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study [Recruiting]

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD [Not yet recruiting]

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration [Terminated]

Photodynamic and Pharmacologic Treatment of CNV [Completed]

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Completed]

The Avastin vs Visudyne for Neovascular AMD Study [Withdrawn]

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. [Terminated]

Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy [Completed]

Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD [Terminated]

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD [Completed]

Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration [Completed]

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia [Completed]

Lucentis KAV Study [Completed]

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis [Recruiting]

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration [Completed]

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD [Completed]

Photodynamic Therapy in Occult-Only Lesions (POOL) [Completed]

Immediate Effects of Lucentis« in Conjunction With Photodynamic Therapy With Visudyne« in Exudative AMD(IECOMB) [Completed]

A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration [Completed]

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration [Completed]

Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) [Completed]

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD) [Completed]

Photodynamic Therapy With Verteporfin for Corneal Neovascularization [Completed]

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia [Completed]

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy [Not yet recruiting]

Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) [Withdrawn]

MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) [Terminated]

A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes [Recruiting]

Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration [Recruiting]

Photodynamic Therapy for the Treatment of Vertebral Metastases [Recruiting]

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD [Withdrawn]

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy [Withdrawn]

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration [Not yet recruiting]

Cohort Study of the Clinical Course of Macular Diseases in Kagawa [Recruiting]

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration [Recruiting]

Treatment of Age-Related Macular Degeneration With Anecortave Acetate [Completed]

Aflibercept in Polypoidal Choroidal Vasculopathy [Recruiting]

VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration) [Completed]

Use of Spectral OCT in Combination Therapy [Completed]

PDT Study for Exudative AMD With PCV [Completed]

Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) [Recruiting]

Cohort Study of the Clinical Course of Macular Diseases in Japanese [Recruiting]

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) [Completed]

Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) [Completed]

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization [Recruiting]

Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration [Completed]

TAC-PF, Avastin« in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration [Terminated]

Photodynamic Therapy for PDA in NV AMD [Recruiting]

Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy [Active, not recruiting]

Combination Therapy for Age-Related Macular Degeneration. [Completed]

Ranibizumab and Reduced Fluence PDT for AMD [Completed]

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma [Completed]

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors [Recruiting]

Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy [Recruiting]

Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD [Recruiting]

Macugen for Histoplasmosis [Terminated]

Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD. [Active, not recruiting]

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. [Completed]

Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy [Completed]

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy [Completed]

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate) [Completed]

Avastin for CNV Secondary to Pattern Dystrophy [Recruiting]

Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains [Completed]

The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy [Recruiting]

Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration [Completed]

Retaane« in Age-Related Macular Degeneration [Completed]

Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy [Completed]

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Recruiting]

Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017